Wells Fargo
FLNA

Wells Fargo’s Filana Therapeutics FLNA Stock Holding History

Wells Fargo’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.2K Sell
8,421
-7,883
-48% -$16.2K ﹤0.01% 5876
2025
Q4 		$32.3K Sell
16,304
-3,579
-18% -$11.5K ﹤0.01% 5673
2025
Q3 		$57.9K Sell
19,883
-3,500
-15% -$8.05K ﹤0.01% 5514
2025
Q2 		$42.3K Sell
23,383
-2,238
-9% -$3.98K ﹤0.01% 5566
2025
Q1 		$38.4K Sell
25,621
-4,383
-15% -$11.1K ﹤0.01% 5485
2024
Q4 		$70.8K Buy
30,004
+4,044
+16% +$71K ﹤0.01% 5367
2024
Q3 		$764K Buy
25,960
+8,410
+48% +$194K ﹤0.01% 3717
2024
Q2 		$217K Buy
17,550
+1,196
+7% +$25.2K ﹤0.01% 4466
2024
Q1 		$332K Buy
16,354
+2,174
+15% +$50.1K ﹤0.01% 4157
2023
Q4 		$319K Buy
14,180
+1,639
+13% +$34.6K ﹤0.01% 4171
2023
Q3 		$209K Sell
12,541
-7,639
-38% -$151K ﹤0.01% 4327
2023
Q2 		$495K Buy
20,180
+9,588
+91% +$231K ﹤0.01% 3946
2023
Q1 		$255K Buy
10,592
+7,368
+229% +$204K ﹤0.01% 4290
2022
Q4 		$95.2K Sell
3,224
-354
-10% -$12.7K ﹤0.01% 4554
2022
Q3 		$150K Buy
3,578
+1,287
+56% +$34.8K ﹤0.01% 4393
2022
Q2 		$64K Sell
2,291
-7,783
-77% -$197K ﹤0.01% 4907
2022
Q1 		$374K Sell
10,074
-30,226
-75% -$1.28M ﹤0.01% 4612
2021
Q4 		$1.76M Buy
40,300
+14,823
+58% +$777K ﹤0.01% 3622
2021
Q3 		$1.58M Buy
25,477
+10,396
+69% +$868K ﹤0.01% 3873
2021
Q2 		$1.29M Sell
15,081
-18,783
-55% -$1.01M ﹤0.01% 4033
2021
Q1 		$1.52M Sell
33,864
-130,707
-79% -$5.14M ﹤0.01% 3934
2020
Q4 		$1.12M Buy
164,571
+107,286
+187% +$958K ﹤0.01% 3944
2020
Q3 		$660K Buy
57,285
+15,079
+36% +$68K ﹤0.01% 4153
2020
Q2 		$130K Buy
42,206
+39,409
+1,409% +$179K ﹤0.01% 5103
2020
Q1 		$12K Buy
2,797
+2,024
+262% +$13.4K ﹤0.01% 5718
2019
Q4 		$4K Buy
773
+572
+285% +$988 ﹤0.01% 6083
2019
Q3 		$0 Hold
201
– – ﹤0.01% 6660
2019
Q2 		$0 Sell
201
-616
-75% -$699 ﹤0.01% 6581
2019
Q1 		$1K Sell
817
-146
-15% -$167 ﹤0.01% 5958
2018
Q4 		$1K Sell
963
-187
-16% -$215 ﹤0.01% 6299
2018
Q3 		$1K Hold
1,150
– – ﹤0.01% 6315
2018
Q2 		$2K Hold
1,150
– – ﹤0.01% 6193
2018
Q1 		$8K Sell
1,150
-88
-7% -$594 ﹤0.01% 5986
2017
Q4 		$5K Sell
1,238
-57
-4% -$230 ﹤0.01% 6056
2017
Q3 		$6K Sell
1,295
-386
-23% -$1.38K ﹤0.01% 5989
2017
Q2 		$7K Sell
1,681
-290
-15% -$1.37K ﹤0.01% 5854
2017
Q1 		$12K Hold
1,971
– – ﹤0.01% 5838
2016
Q4 		$8K Buy
1,971
+171
+10% +$793 ﹤0.01% 5861
2016
Q3 		$13K Hold
1,800
– – ﹤0.01% 5710
2016
Q2 		$28K Hold
1,800
– – ﹤0.01% 5400
2016
Q1 		$28K Buy
1,800
+371
+26% +$4.8K ﹤0.01% 5417
2015
Q4 		$18K Buy
1,429
+415
+41% +$5.49K ﹤0.01% 5608
2015
Q3 		$13K Buy
1,014
+218
+27% +$2.75K ﹤0.01% 5656
2015
Q2 		$10K Buy
796
+493
+163% +$6.75K ﹤0.01% 5812
2015
Q1 		$4K Sell
303
-378
-56% -$5.1K ﹤0.01% 5867
2014
Q4 		$10K Sell
681
-7,577
-92% -$131K ﹤0.01% 5636
2014
Q3 		$226K Buy
8,258
+7,871
+2,034% +$239K ﹤0.01% 4300
2014
Q2 		$16K Sell
387
-2,134
-85% -$79K ﹤0.01% 5467
2014
Q1 		$97K Buy
+2,521
New +$89K ﹤0.01% 4667
2013
Q4 		– Hold
0
– – – 5893
2013
Q3 		– Hold
0
– – – 5812
2013
Q2 		– Hold
0
– – – 5680

Other funds holding FLNA

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo's FLNA Position: Q1 2026 in Review

Wells Fargo reduced its Filana Therapeutics (FLNA) stake by 48% in Q1 2026, selling an estimated $16.2K and leaving 8,421 shares worth $14.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5876.

Wells Fargo first reported a position in FLNA in Q1 2014 and has held it in 49 quarters since. The position peaked at $1.76M in Q4 2021. 101 funds tracked by Wall St. Rank hold FLNA as of Q1 2026.

  • Wells Fargo held 8,421 shares of Filana Therapeutics worth $14.2K as of Q1 2026.
  • Wells Fargo sold 7,883 Filana Therapeutics shares in Q1 2026, an estimated $16.2K.
  • Filana Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5876 holding.
  • Wells Fargo first reported a position in Filana Therapeutics in Q1 2014 and has held it in 49 quarters since.
  • Wells Fargo's Filana Therapeutics position peaked at $1.76M in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Filana Therapeutics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.